This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sudo Biosciences Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Swapan Kumar Samanta: Innovator in TYK2 Inhibitors
Introduction
Swapan Kumar Samanta is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of TYK2 inhibitors. His work focuses on compounds that can modulate TYK2 activity, which is crucial for treating various conditions and diseases.
Latest Patents
Swapan Kumar Samanta holds 1 patent for his invention titled "TYK2 inhibitors and uses thereof." This patent describes compounds that act as TYK2 inhibitors, methods for synthesizing these compounds, and their applications in pharmaceutical compositions. The invention aims to provide effective treatments for conditions that benefit from the modulation of TYK2 activity.
Career Highlights
Samanta is currently associated with Sudo Biosciences Limited, where he continues to advance his research and development efforts. His expertise in the pharmaceutical industry has positioned him as a key player in the innovation of therapeutic solutions.
Collaborations
Some of his notable coworkers include Anjali Pandey and Gregory Dietsch, who contribute to the collaborative environment at Sudo Biosciences Limited. Their combined efforts enhance the research and development capabilities of the company.
Conclusion
Swapan Kumar Samanta's work in TYK2 inhibitors represents a significant advancement in pharmaceutical innovation. His contributions are poised to impact the treatment of various diseases, showcasing the importance of research in developing effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile